[Maintenance therapy with biologic agents for Crohn's disease: impact of scheduled maintenance therapy with infliximab]

Nihon Shokakibyo Gakkai Zasshi. 2011 Mar;108(3):401-9.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Crohn Disease / drug therapy*
  • Female
  • Gastrointestinal Agents / administration & dosage
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infliximab
  • Male

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab